BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31657556)

  • 1. Enhancing the Cell Permeability of Stapled Peptides with a Cyclic Cell-Penetrating Peptide.
    Dougherty PG; Wen J; Pan X; Koley A; Ren JG; Sahni A; Basu R; Salim H; Appiah Kubi G; Qian Z; Pei D
    J Med Chem; 2019 Nov; 62(22):10098-10107. PubMed ID: 31657556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy.
    Chang YS; Graves B; Guerlavais V; Tovar C; Packman K; To KH; Olson KA; Kesavan K; Gangurde P; Mukherjee A; Baker T; Darlak K; Elkin C; Filipovic Z; Qureshi FZ; Cai H; Berry P; Feyfant E; Shi XE; Horstick J; Annis DA; Manning AM; Fotouhi N; Nash H; Vassilev LT; Sawyer TK
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3445-54. PubMed ID: 23946421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angler Peptides: Macrocyclic Conjugates Inhibit p53:MDM2/X Interactions and Activate Apoptosis in Cancer Cells.
    Philippe GJ; Mittermeier A; Lawrence N; Huang YH; Condon ND; Loewer A; Craik DJ; Henriques ST
    ACS Chem Biol; 2021 Feb; 16(2):414-428. PubMed ID: 33533253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of Putative Helix-Breaking Amino Acids in the Design of Novel Stapled Peptides: Exploring Biophysical and Cellular Permeability Properties.
    Partridge AW; Kaan HYK; Juang YC; Sadruddin A; Lim S; Brown CJ; Ng S; Thean D; Ferrer F; Johannes C; Yuen TY; Kannan S; Aronica P; Tan YS; Pradhan MR; Verma CS; Hochman J; Chen S; Wan H; Ha S; Sherborne B; Lane DP; Sawyer TK
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31226791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Hierarchical Peptide-Lanthanide Framework To Accurately Redress Intracellular Carcinogenic Protein-Protein Interaction.
    Yan J; Yan S; Hou P; Lu W; Ma PX; He W; Lei B
    Nano Lett; 2019 Nov; 19(11):7918-7926. PubMed ID: 31645103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Membrane Composition Drives Selectivity and Toxicity of Designed Cyclic Helix-Loop-Helix Peptides with Cell Penetrating and Tumor Suppressor Properties.
    Philippe GJ; Gaspar D; Sheng C; Huang YH; Benfield AH; Condon ND; Weidmann J; Lawrence N; Löwer A; Castanho MARB; Craik DJ; Troeira Henriques S
    ACS Chem Biol; 2019 Sep; 14(9):2071-2087. PubMed ID: 31390185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Permeable Stapled Peptide Inhibitor of Wnt Signaling that Targets β-Catenin Protein-Protein Interactions.
    Dietrich L; Rathmer B; Ewan K; Bange T; Heinrichs S; Dale TC; Schade D; Grossmann TN
    Cell Chem Biol; 2017 Aug; 24(8):958-968.e5. PubMed ID: 28757184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of cell-penetrating peptide-based drug leads to inhibit MDMX:p53 and MDM2:p53 interactions.
    Philippe G; Huang YH; Cheneval O; Lawrence N; Zhang Z; Fairlie DP; Craik DJ; de Araujo AD; Henriques ST
    Biopolymers; 2016 Nov; 106(6):853-863. PubMed ID: 27287767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. d-Amino acid mutation of PMI as potent dual peptide inhibitors of p53-MDM2/MDMX interactions.
    Li X; Liu C; Chen S; Hu H; Su J; Zou Y
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4678-4681. PubMed ID: 28916339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible Bicyclization.
    Qian Z; Rhodes CA; McCroskey LC; Wen J; Appiah-Kubi G; Wang DJ; Guttridge DC; Pei D
    Angew Chem Int Ed Engl; 2017 Feb; 56(6):1525-1529. PubMed ID: 28035784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing Cell-Permeable Macrocyclic Peptides.
    Appiah Kubi G; Dougherty PG; Pei D
    Methods Mol Biol; 2019; 2001():41-59. PubMed ID: 31134566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression.
    Chen S; Li X; Li Y; Yuan X; Geng C; Gao S; Li J; Ma B; Wang Z; Lu W; Hu HG
    Theranostics; 2022; 12(15):6665-6681. PubMed ID: 36185610
    [No Abstract]   [Full Text] [Related]  

  • 13. A Cyclized Helix-Loop-Helix Peptide as a Molecular Scaffold for the Design of Inhibitors of Intracellular Protein-Protein Interactions by Epitope and Arginine Grafting.
    Fujiwara D; Kitada H; Oguri M; Nishihara T; Michigami M; Shiraishi K; Yuba E; Nakase I; Im H; Cho S; Joung JY; Kodama S; Kono K; Ham S; Fujii I
    Angew Chem Int Ed Engl; 2016 Aug; 55(36):10612-5. PubMed ID: 27467415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetra-substituted imidazoles as a new class of inhibitors of the p53-MDM2 interaction.
    Vaupel A; Bold G; De Pover A; Stachyra-Valat T; Lisztwan JH; Kallen J; Masuya K; Furet P
    Bioorg Med Chem Lett; 2014 May; 24(9):2110-4. PubMed ID: 24704029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing dual inhibitors of Mdm2/MdmX: Unexpected coupling of water with gatekeeper Y100/99.
    Lee XA; Verma C; Sim AYL
    Proteins; 2017 Aug; 85(8):1493-1506. PubMed ID: 28425639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-based inhibitors of protein-protein interactions.
    Wójcik P; Berlicki Ł
    Bioorg Med Chem Lett; 2016 Feb; 26(3):707-713. PubMed ID: 26764190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical assessment of the synthesis and biological activity of p53/human double minute 2-stapled peptide inhibitors.
    Wallbrecher R; Chène P; Ruetz S; Stachyra T; Vorherr T; Brock R
    Br J Pharmacol; 2017 Aug; 174(16):2613-2622. PubMed ID: 28436014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hDM2 protein-binding peptides screened from stapled α-helical peptide phage display libraries with different types of staple linkers.
    Anananuchatkul T; Tsutsumi H; Miki T; Mihara H
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127605. PubMed ID: 33038548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity.
    Brandão P; Loureiro JB; Carvalho S; Hamadou MH; Cravo S; Moreira J; Pereira D; Palmeira A; Pinto M; Saraiva L; Cidade H
    Eur J Med Chem; 2018 Aug; 156():711-721. PubMed ID: 30041135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing Specific Disruption of Intracellular Protein Complexes by Hydrocarbon Stapled Peptides Using Lipid Based Delivery.
    Thean D; Ebo JS; Luxton T; Lee XC; Yuen TY; Ferrer FJ; Johannes CW; Lane DP; Brown CJ
    Sci Rep; 2017 May; 7(1):1763. PubMed ID: 28496125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.